AI assistant
ABBOTT LABORATORIES — Director's Dealing 2008
Feb 21, 2008
29777_dirs_2008-02-20_3891b260-1654-4574-a5d0-b59d8805c4c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-02-15
Reporting Person: Landgraf John C (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2008-02-15 | Common shares without par value | A | 19700 | $55.56 | Acquired | 103907 | Direct |
| 2008-02-17 | Common shares without par value | F | 2602 | $55.55 | Disposed | 101305 | Direct |
| 2008-02-18 | Common shares without par value | F | 1186 | $55.55 | Disposed | 100119 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-02-15 | Option (right to buy) | $55.56 | A | 78700 | Acquired | 2018-02-14 | common shares (78700) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common shares without par value | 15494 | Indirect |
| Common shares without par value | 25000 | Indirect |
| Common shares without par value | 1296 | Indirect |
Footnotes
F1: These shares represent performance vested restricted stock awards under the Abbott Laboratories 1996 Incentive Stock Program. The awards have a 5-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The awards include the right to have stock withheld for tax purposes.
F2: Balance in the Abbott Laboratories Stock Retirement Trust as of February 14, 2008.
F3: Held in the Anne Marie Landgraf Living Trust. The reporting person and his spouse are co-trustees. The trust is revocable by his spouse.
F4: Includes shares acquired under the Abbott Laboratories Dividend Reinvestment and Stock Purchase Plan in transactions exempt from Section 16 under Rule 16(a)-11.
F5: The reporting person disclaims beneficial ownership of all securities held by his son.
F6: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 26,234 on 02/15/2009, 26,233 on 02/15/2010, and 26,233 on 02/15/2011.